The companies have signed an agreement that enables Medrad to sell CADstream in the UK, Germany and Italy. Under the agreement, Confirma will install, train and support all CADstream customers.
Pursuant to this agreement, Medrad will be selling Confirma’s next-generation CADstream, version 5.0, for breast and prostate in the EU. This version of CADstream is currently under clinical investigation in the US.
CADstream is said to be a CAD operating system designed specifically for radiology networks and workflow-specific MRI applications. The system automates the analysis, reporting, and interventional planning of studies and promotes standardization of MRI studies with the incorporation of recognized standards.
Wayne Wager, president and CEO of Confirma, said: “Our partnership with Medrad will make CADstream available to more physicians and patients, ultimately helping improve patient care in the EU. With their customer relationships, dedication to the radiology market and reputation as a leader in medical imaging devices, Medrad will be a strong partner.”